Free Trial

National Wealth Management Group LLC Buys New Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • National Wealth Management Group LLC invested $419,000 in The Clorox Company by purchasing 2,847 shares during the first quarter.
  • Clorox recently reported $2.87 earnings per share for the last quarter, exceeding analysts' expectations of $2.24, with a 4.5% increase in revenue year-over-year.
  • The company declared a quarterly dividend of $1.24 per share, up from the previous $1.22, representing an annual yield of 4.0%.
  • Interested in Clorox? Here are five stocks we like better.

National Wealth Management Group LLC bought a new position in The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,847 shares of the company's stock, valued at approximately $419,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of Clorox by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after acquiring an additional 65,924 shares in the last quarter. Northern Trust Corp lifted its holdings in Clorox by 2.3% during the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock worth $225,133,000 after buying an additional 34,655 shares in the last quarter. Invesco Ltd. lifted its holdings in Clorox by 7.4% during the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock worth $200,512,000 after buying an additional 94,371 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Clorox by 12.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock worth $181,213,000 after buying an additional 123,200 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in Clorox by 118.8% during the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after buying an additional 589,544 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.57% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company reduced their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. JPMorgan Chase & Co. upped their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday. Barclays reduced their price objective on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. Finally, Morgan Stanley cut their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. One analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce" and a consensus target price of $142.18.

Check Out Our Latest Stock Analysis on CLX

Clorox Stock Down 2.2%

Shares of NYSE CLX traded down $2.72 during mid-day trading on Wednesday, hitting $122.97. The company had a trading volume of 484,641 shares, compared to its average volume of 1,665,341. The company has a market capitalization of $15.04 billion, a PE ratio of 18.86, a price-to-earnings-growth ratio of 1.01 and a beta of 0.52. The firm has a 50-day simple moving average of $124.33 and a two-hundred day simple moving average of $132.94. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a one year low of $116.53 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were paid a $1.24 dividend. This is an increase from Clorox's previous quarterly dividend of $1.22. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox's dividend payout ratio (DPR) is 76.07%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.